PBM

Propel Bio Management Portfolio holdings

AUM $82.4M
1-Year Est. Return 29.33%
This Quarter Est. Return
1 Year Est. Return
+29.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$172M
AUM Growth
+$18.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1
+$1.25M
2
+$1.01M
3
+$963K
4
CMPS
Compass Pathways
CMPS
+$504K
5
AKRO icon
Akero Therapeutics
AKRO
+$458K

Top Sells

1
+$4.65M
2
+$3.94M
3
+$1.85M
4
KYN icon
Kayne Anderson Energy Infrastructure Fund
KYN
+$1.52M
5
TRVI icon
Trevi Therapeutics
TRVI
+$775K

Sector Composition

1 Healthcare 83.54%
2 Energy 13.65%
3 Technology 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$55.8M 32.38%
6,567,858
2
$23.5M 13.65%
1,272,360
-100,000
3
$15.7M 9.12%
869,927
4
$11.6M 6.74%
2,453,092
5
$10.4M 6.03%
2,087,139
6
$9.86M 5.72%
343,729
+15,977
7
$9.13M 5.3%
43,032
8
$8.2M 4.76%
178,500
9
$7.38M 4.28%
1,070,947
+146,364
10
$4.82M 2.79%
365,781
11
$3.94M 2.29%
624,022
-624,022
12
$2.67M 1.55%
56,359
13
$2.57M 1.49%
133,259
+50,000
14
$2.54M 1.47%
130,000
15
$1.25M 0.72%
+179,874
16
$1.24M 0.72%
146,381
17
$666K 0.39%
1,492,792
18
$504K 0.29%
+80,000
19
$500K 0.29%
34,494
-8,000
20
– –
-22,368
21
– –
-750,000
22
– –
-147,033
23
– –
-260,000